Combating Unsafe Medical Products: Outcomes of a Survey on Testing of Suspect Medicines. (WHO Drug Information Vol. 28, No. 3, 2014)
(2014; 7 pages)


Spurious, falsely-labelled, falsified and/or counterfeit products infiltrating the pharmaceutical supply chains continue to pose a global public health risk. Strategic quality control (QC) testing is a cornerstone of the fight against these products. A survey among QC laboratories in all six WHO regions has provided more insight on how this testing is conducted in Member States.

Le Portail d'information - Médicaments essentiels et produits de santé a été conçu et est maintenu par l'ONG Human Info. Dernière mise à jour: le 1 décembre 2019